Research!America's Top 10 Most Popular Guest Blogs of 2018
Looking back at 2018, it is important to note the amazing contributions that have been made to science, research and advocacy made by some truly outstanding individuals. Research!America has had the honor of featuring a few of these science leaders as guest contributors to our blog, which gives us the opportunity to share their work and opinions on a broader scale. As the year comes to a close, we’d like to take a moment to look back at our 10 most popular guest blog posts from 2018.
June 28: In our most-read blog, Heather Snyder, senior director of medical and scientific operations at the Alzheimer’s Association, discussed the importance of the formation of the U.S. POINTER Study. This study was initiated by the Alzheimer’s Association in order to assess how lifestyle factors, such as diet and exercise, can affect cognitive function in those at risk for cognitive decline. The U.S. POINTER Study has the potential for bring valid, reliable answers to the many uncertainties Alzheimer’s patients face every day.
September 19: Our second most popular blog post was written by Dr. Eric Verdin, President and CEO of the Buck Institute on Aging.His blog, written in honor of Healthy Aging Month in September, discussed the Buck Institute’s research on the biological processes of aging. He noted that investing in research on aging can mean a better, more full life for the entire aging population.
May 8: Tamar Rodney, MSN, RN, a Geneva Foundation/Jonas Veterans Healthcare Scholar at Johns Hopkins University School of Nursing, discussed her research on which biomarkers can be used to predict the development of Post-Traumatic Stress Disorder (PTSD) after experiencing a Traumatic Brain Injury (TBI). She noted that the results of this research is especially relevant to veterans, who are highly likely to experience a TBI as well as the life altering effects of PTSD. This blog was featured in a series that highlighted nursing research in honor of National Nursing Week.
May 3: Another installment of the nursing research blog series was provided by Bernadette Mazurek Melnyk, PhD, RN, APRN-CNP, the Vice President for Health Promotion, University Chief Wellness Officer, Dean and Professor, College of Nursing; Professor of Pediatrics and Psychiatry, College of Medicine and Executive Director, The Helene Fuld Health Trust National Institute for EBP, The Ohio State University. She highlighted the many accomplishments of nursing research, and noted the importance of translating the outcomes of nursing research into clinical practices.
August 28: Joseph Coe, migraine patient and director of digital content and patient advocacy for the Global Healthy Living Foundation, began by highlighting that there are 39 million people in the United States living with migraine. He then wrote about the importance of migraine patient advocacy, and included some tips for how to live fully with migraines, including sharing your experiences with those around you, and reaching out to other fellow migraine patients to build a support system.
February 1: Ambassador Sally G. Cowal, senior vice president of global cancer control at the American Cancer Society, pointed out that the majority of the world’s cancer cases and cancer deaths occur in Low- or Middle-Income Countries (LMIC), confirming the need for global cancer efforts. She remarked on the work the American Cancer Society has done to collaborate with health leaders to improve the patient experience and remove or reduce barriers to getting access to treatment.
January 25: Matt Windsor, PhD, senior manager of science communications at the Association for Research in Vision and Ophthalmology, discussed the progress of glaucoma research in honor of Glaucoma Awareness Month in January. He wrote about what a patient with glaucoma experiences, and highlighted the approval of two new pharmaceutical treatments that can greatly improve this experience.
October 1: Srini Ramanathan, PhD, Vice President of Development Sciences at Horizon Pharma, discussed the challenges that rare diseases pose, and highlighted areas of opportunity for collaboration. He noted that combining the efforts of patient advocacy groups, pharmaceutical companies, and the medical community has the potential to improve patient treatment plans and expedite the process of finding treatments and cures to the many rare diseases Americans face.
October 29: Jill Inverso, Vice President of Global Medical Affairs and Anti-Infectives at Pfizer, contributed to our AMR blog series, held in honor of World Antibiotic Awareness Week in November. She reported on the many potential consequences of antimicrobial resistance, and noted the responsibilities government and industry have in order to slow the progression of antimicrobial resistance. She also included tips that everyone can integrate into their life to contribute to these preventative efforts.
February 23: 2018 marked the 70th anniversary of the Framingham Heart Study’s formation, and to celebrate, the American Heart Association wrote about the contributions the results of this study has made on health care. The Framingham Heart Study is an ongoing cohort study that seeks to find the many factors that are associated to cardiovascular disease. Findings from this study have helped to create policy, clinical practice, and health care messaging as we know it.
We’d like to thank all those who contributed these blogs, as well as to all those who read, shared, and incorporated this information into their work.